Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
Background: Recurrent Clostridioides difficile infection (CDI) is associated with significant morbidity, mortality, and healthcare-related costs. Although data are minimal, agents including oral vancomycin have been used as secondary prophylaxis to prevent recurrent CDI. Methods: We conducted a rand...
Saved in:
Main Authors: | Zeitler Kristen (Author), Andrew Nguyen (Author), Candice Mateja (Author), Ripal Jariwala (Author), Carlos Bertran-Rodriguez (Author), Cynthia Mayer (Author), Diep Nguyen (Author), Mindy Sampson (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of oral vancomycin as prophylaxis against Clostridioides difficile infection in hematopoietic stem cell transplant patients
by: Kelly M. Reitmeyer, et al.
Published: (2024) -
The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
by: Ronald G. Hall, et al.
Published: (2022) -
Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients
by: A. Krishna Rao, et al.
Published: (2022) -
Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients
by: Diaa Alrahmany, et al.
Published: (2021) -
Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent Clostridioides difficile infection in the Japanese setting: a case control study
by: Takumi Umemura, et al.
Published: (2019)